Texas Attorney General Ken Paxton has announced a $290 million statewide opioid settlement agreement with Johnson & Johnson to resolve opioid-related claims. The agreement will largely track the terms of the Global Prescription Opioid Litigation Settlement Agreement that was announced July 23, 2021. According to the settlement, Johnson & Johnson has agreed to pay $291,841,754.89 into the Qualified Settlement Fund, representing Texas’s allocation of the Global Abatement Settlement.
In addition to the funds from Johnson & Johnson, Texas could also receive up to $1.2 billion from three distributors, which will bring to Texas up to $1.5 billion in funding for statewide opioid abatement efforts.
See the settlement agreement here.